Tenaya Therapeutics (TNYA) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Tenaya Therapeutics Revenue Highlights


00

Tenaya Therapeutics Revenue by Period


Tenaya Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Tenaya Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Tenaya Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$17.66M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Tenaya Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Tenaya Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
OCULOcular Therapeutix$58.44M$14.71M
BCYCBicycle Therapeutics$26.98M$2.68M
STOKStoke Therapeutics$8.78M$4.22M
IGMSIGM Biosciences$2.13M$497.00K
FIXXQ32 Bio$1.16M-
EYENEyenovia$3.79K$4.99K
CRVSCorvus Pharmaceuticals--
ALXOALX Oncology--
GOSSGossamer Bio-$95.84M
INZYInozyme Pharma--
DRTSAlpha Tau Medical--
BMEABiomea Fusion--
VINCVincerx Pharma--
GLUEMonte Rosa Therapeutics-$4.70M
AKROAkero Therapeutics--
TNYATenaya Therapeutics--
RANIRani Therapeutics--

TNYA Revenue FAQ


Tenaya Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TNYA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Tenaya Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TNYA's quarterly revenue for Q4 2023 was $17.66M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Tenaya Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.